Posted inBiotechnology
Food Focus in Binge Eating: Training Limitations Revealed
In a groundbreaking study by Sablottny et al., researchers have delved into the complex interplay between attentional bias and binge…
Posted inBiotechnology
Double Disadvantage: The Impact is Greater Than Twice as Severe
In the evolving landscape of social sciences, a groundbreaking study emerges from the Complexity Science Hub (CSH) and Graz University…
Posted inGenetics
FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency
Credit: hapabapa / Editorial RF / iStock Editorial / Getty Images Plus Thymidine kinase 2 deficiency (TK2d) is an ultra-rare…
Posted inGenetics
Ginkgo Bioworks Awarded Project Agreement Through BARDA’s BioMaP-Consortium
Credit: Ginkgo Bioworks Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical…
Posted inBiotechnology
Judge knocks down Pfizer’s effort to block Novo’s rival bid for Metsera
Amid the rapidly unfolding saga revolving around Metsera, a judge has denied Pfizer’s request to block Novo Nordisk’s buyout bid…
Posted inGenetics
Adsorption Remains a Sticky Problem
Accumulation on surfaces is a big problem for protein drug makers. Such interactions impact drug efficacy and stability and can…
Posted inGenetics
Small Biotechs Should Develop Bioprocesses Early
Startup companies should draw upon expertise early in process development to avoid losing time on repeating scale-up or manufacturing-quality batches.…
Posted inGenetics
Single-Pass Nanofilter for Oligosaccharide/Nucleoside Mixes
The downstream processing and purification of glycans has been challenging for biopharmaceutical manufacturers because of the intricate mixtures of sugars,…
Posted inGenetics
Optimizing CAR T Manufacturing With Automation and Global Networks
As demand for precision medicine accelerates, CAR T and CAR Treg cell therapies are emerging as crucial tools in the…
Posted inBiotechnology
FTC warns Novo that current Metsera offer structure may violate US merger law
As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the…